Operation Warp Speed expands governmental effort on vaccine, therapeutic and diagnostic countermeasures to Covid-19
Trump administration goal: ‘substantial quantities of a safe and effective vaccine available for Americans by January 2021’
US law firm is first to acquire a dot-pharmacy address
Quarles & Brady garners an innovative distinction
More options for recyclable cold-chain containers
More packaging vendors are offering ‘curbside recyclable’ containers
How to successfully transition patient solutions providers
Reasons for, and actions to take, when switching hub service providers
The beginnings of a ‘Covid-19’ industry
Milken Institute survey finds nearly 300 therapies and vaccines
FDA loosens some DSCSA restrictions for the duration of the Covid-19 emergency
Strains are showing in drug supplies consumed in treating infected patients
Innovative models to address cell- and gene-therapy (CGT) payer challenges
Carving out CGTs for payment systems involving government intervention may be an answer
Cold-chain service providers realign, expand
DuPont/Cold Chain Technologies in thermal blankets; va-Q-tec in shipment tracking; big bucks for SkyCell
Drone delivery of pharmaceuticals takes flight in Florida
UPS and CVS Pharmacy collaborate for direct-to-patient delivery; but check out Matternet, UPS’ drone partner
2020 Biopharma Cold Chain Sourcebook forecasts a $17.2-billion logistics market
Cellular and genetic therapies (CGTs) are a minor part of commercial business, but a growing part of research activity
Hospital pharmacy survey finds a lack of visibility to internal inventories
Kit Check data show value of track-and-trace technology, especially during the Covid-19 pandemic
Model N survey highlights the growing complexity of revenue management
Revenue leakage in contracting and sales execution affects 95% of respondents
Integrichain adds more managed services to its commercialization IT business
Acquisition of Cumberland Life Sciences boosts its client base and range of services
The new normal in pharma and clinical trial logistics
Service providers are resetting their business practices to cope with the pandemic
Patient support in the pandemic era
Hub service providers look to telehealth to expand patient connectivity
Navigating the patient journey after rare disease diagnosis
Commercial teams can prepare for overcoming predictable hurdles
For DEA, the opioid-abuse epidemic is being superseded by the Covid-19 pandemic
Production quotas for controlled substances are being raised by 15%
Biotech developmental resources have a new brand: Cytiva
Now a Danaher Corp. asset, the former GE Healthcare Life Sciences business has been reshuffled
The muddled and uncertain future of the chloroquine/hydroxychloroquine ‘cure’ for Covid-19
Newly initiated trials may prove value—but even then, supplies may be limited, and hoarding is already occurring
Evolving Patient Access Programs for Specialty Therapies
When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies
Tips on running virtual meetings
For sessions with co-workers or clients, consider these recommendations
Milken Institute publishes a Covid-19 Tracker to monitor therapy development
As of March 26, 71 treatments and 47 vaccines are in development
Sales growth of pharmaceuticals is slowing globally, says IQVIA annual study
US list-price sales reached $510 billion in 2019
Air cargo stutters, then responds to coronavirus pandemic
Passenger-based carriers are repurposing their flights
Pharma distributors adjust to the Covid-19 pandemic
Healthcare Ready pools industry efforts
DEA weighs in on Covid-19 response
DEA-registered practitioners can prescribe without an in-person interview
DHS national guidance: pharma distribution/logistics staff are ‘critical infrastructure workers’ during Covid-19 crisis
Guidance enables these workers to continue reporting to work
Specialty pharmaceutical patients ‘have difficulty’ obtaining their first dose
CoverMyMeds report gives evidence of ongoing difficulties in patient support
Global site selection comparative costs: India is the global low-cost producer
Copenhagen, Denmark tops Boyd Co.’s list with the highest annual operating costs
ARM assesses pace of cellular, genetic and tissue therapy development
But: the growth number of companies is exceeding the growth of trials
